Radiation Safety & Regulations Source Activity Limits
Source Activity Limits for Teletherapy and Brachyther-
apy in India: Clinical Guidelines and Regulatory Frame-
work
A Comprehensive Analysis of Activity Limits,
Regulatory Requirements, and Clinical Acceptability
Compiled by: PRASANTH R, [Link]. MEDICAL PHYSICS
1. Introduction
The utilization of radioactive sources in external beam teletherapy and brachytherapy represents
a cornerstone of cancer treatment in India. This analysis examines the activity limits, regu-
latory requirements, and clinical acceptability criteria for Cobalt-60 (Co-60) teletherapy
sources and brachytherapy sources, emphasizing the relationship between source activity, half-
life decay, and clinical viability within the Indian healthcare context.
2. Cobalt-60 Teletherapy: Activity Specifications
Initial Source Loading Activity
Co-60 teletherapy units in India are typically loaded with sources having initial activities rang-
ing from 222 TBq (6,000 Ci) to 444 TBq (12,000 Ci), with the most common configuration
being 333 TBq (9,000 Ci).
The indigenous Bhabhatron-II telecobalt unit, developed by BARC, has a maximum
source capacity of 555 TBq (250 RMM ≈ 15,000 Ci). The initial dose rate for a typical
333 TBq source is approximately 2.8 Gy/min at 80 cm SSD (168 Gy/hr).
[Image of Bhabhatron-II telecobalt unit]
Minimum Acceptable Activity for Clinical Treatment
The lower activity limit is determined by treatment time and workflow efficiency.
• A source output below 50 cGy/hr (0.5 Gy/hr) at 80 cm is considered clinically un-
acceptable.
• This corresponds to a dose rate of 0.008-0.01 Gy/min.
• Source replacement typically occurs every 5-7 years.
[Image of Cobalt-60 decay curve activity vs time]
1
Radiation Safety & Regulations Source Activity Limits
Key Constants & Formulas
Cobalt-60 Decay Parameters:
• Half-Life (T1/2 ): 5.27 years
• Decay Rate: ≈ 1.089% per month
• Decay Formula: At = A0 e−λt
• After 5 Years: 333 TBq decays to ≈ 173 TBq (1.45 Gy/min)
• After 10 Years: Decays to ≈ 89 TBq (0.75 Gy/min)
Maximum Activity and Safety
Maximum permissible activity is governed by shielding.
• Bhabhatron-II Limit: 555 TBq (15,000 Ci)
• Imported Units Limit: 370-444 TBq (10,000-12,000 Ci)
• AERB Limit: Leakage radiation at 1 meter (OFF position) shall not exceed 20 µSv/hr
at maximum capacity.
3. Brachytherapy Sources: Activity Replacement
Iridium-192 High-Dose-Rate (HDR)
Ir-192 is the predominant isotope for HDR brachytherapy in India.
• Initial Activity: 370 GBq (10 Ci) to 481 GBq (13 Ci).
• Dose Rates: 100-300 Gy/hr at standard reference distances.
• Half-Life: 73.83 days (≈ 2.4 months).
• Replacement: Every 3-4 months.
• Minimum Economic Activity: Generally 2 Ci (74 GBq). Below this, treatment
times become impractically long.
Cobalt-60 HDR Brachytherapy
Co-60 offers logistic advantages due to its longer half-life.
• Initial Activity: 74 GBq (2 Ci) to 81.4 GBq (2.2 Ci).
• Dose Rates: 100-200 Gy/hr (Comparable to Ir-192 due to higher Air Kerma Rate
Constant).
• Replacement: Every 5 years (vs. 25 changes for Ir-192).
2
Radiation Safety & Regulations Source Activity Limits
[Image of HDR brachytherapy remote afterloader internal schematic]
Table 1: Comparative Analysis of Physical Constants
Parameter Iridium-192 (Ir-192) Cobalt-60 (Co-60)
Half-Life 73.83 days 5.27 years
Typical Initial Activity (HDR) 10 Ci (370 GBq) 2.0 Ci (74 GBq)
Air Kerma Rate Constant (Γδ ) 110 µGy·m2 ·GBq−1 ·h−1 306 µGy·m2 ·GBq−1 ·h−1
Source Replacement Fre- Every 3-4 Months Every 5 Years
quency
Mean Energy ≈ 0.38 MeV 1.25 MeV
4. Regulatory Framework (AERB)
Regulated by AERB Safety Code AERB/RF-MED/SC-1 (Rev. 1).
Key Regulatory Requirements
• Type Approval: All equipment/sources must be type-approved by AERB.
• Calibration Accuracy: Brachytherapy sources must be calibrated with accuracy
within ± 5%.
• Leakage/Integrity: Sealed sources wipe tested every 6 months. Removable
contamination > 200 Bq is classified as leaky.
• Teletherapy Output QA: Measured to ± 2% at commissioning; weekly con-
stancy within ± 3%.
Indigenous Manufacturing
• BRIT (Board of Radiation and Isotope Technology): Produces indigenous Co-60
pellets.
• Specific Activity: 140-180 Ci/g (Indigenous) vs 300-320 Ci/g (Imported).
• Karknidon-I: Indigenous HDR system for single 15 Ci Ir-192 sources.
5. Clinical & Economic Considerations
Decay Impact on Planning
• Co-60 Teletherapy: Output drops from 2.8 Gy/min to 1.89 Gy/min after 36 months.
QA protocols require measured output to agree with decay-corrected output within ±
2%.
• Ir-192 HDR: Activity drops to 50% in 74 days, doubling treatment time.
3
Radiation Safety & Regulations Source Activity Limits
Economic Factors
In India, Ir-192 sources are sometimes used below 2 Ci to save costs, reducing throughput. Co-
60 sources offer superior total cost of ownership due to 5-7 year replacement intervals, reducing
shipping, compliance, and disposal costs.
6. Safety Standards and Dose Rate Limits
Table 2: AERB Leakage Radiation Limits (Teletherapy)
Measurement Condition Dose Rate Limit
1 meter from source (Beam OFF) Max 20 µSv/hr
5 cm from accessible surface (Beam OFF) Max 200 µSv/hr
Transmission through collimators Max 0.5% (Telegamma)
Personnel Dose Constraints: Source loading operations must ensure effective dose does not
exceed 1 mSv.
7. Global Context and Clinical Applications
• IAEA/WHO: WHO recommends 1 machine per million population. India has ≈
0.55 per million.
• AAPM TG-43: Standard formalism used in India. Specifies source strength in Air
Kerma Strength (µGy·m2 ·h−1 ).
• Clinical Equivalence: Studies confirm Ir-192 and Co-60 HDR are dosimetrically
equivalent for target coverage, supporting interchangeability based on logistics.
8. Conclusion
The activity limits for Co-60 teletherapy and brachytherapy in India are a balance of physics,
economics, and regulation.
• Teletherapy Cutoff: 50 cGy/hr (approx. 5-7 years).
• Brachytherapy Cutoff: 2 Ci (74 GBq) for economic viability.
• Trend: Transition toward Co-60 HDR for high-volume centers due to 5-year replace-
ment intervals.